
Stericycle Income Statement 2023-2007 | SRCL
Brief overview of revenue and earnings at Stericycle
The comparison covers a five-year financial horizon. Stericycle reported revenue of $853 million in 2018 and $2.7 billion by 2023. The cumulative result was +211.9%, corresponding to roughly 25.5% per year. Sales grew at a rate typical of a strong expansion phase.
The gross result shifted from 1.4 billion dollars to 1 billion dollars, or −26.3%. Direct costs grew more slowly than revenue and improved the economics of sales. At the margin level, the figure shifted from 161.4% to 38.2%. Weakening gross profitability reduces the quality of the top-line trend.
The five-year EBITDA result moved by +612.1%: from −$35.5 million to $182 million. Operating profitability strengthened faster than the scale of sales. The EBITDA share of revenue changed from −4.2% to 6.8%. The increased EBITDA share is a positive sign.
The final result was −$245 million initially and −$21.3 million in the final year. The negative result improved without reaching break-even.
Market capitalization changed from 3.8 billion dollars to 5.1 billion dollars (+34.1%). Investors responded cautiously to the improvement in the business.
Financial takeaway
Positive developments coexist with areas of weakness. The constructive conclusion rests on an improving EBITDA margin, net-income growth and a larger revenue base. The most visible risks are pressure from direct costs. Further direction will depend on top-line growth, operating profitability, and net income.
Annual Income Statement Stericycle
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
5.15 B | 4.49 B | 5.39 B | 5.99 B | 5.7 B | 3.84 B | 6.43 B | 6.55 B | 10.2 B | 11.2 B | 10.1 B | 8.06 B | 7.18 B | - | - | - | - |
Shares |
92.4 M | 92.1 M | 91.8 M | 91.5 M | 91 M | 87.1 M | 85.3 M | 84.9 M | 84.9 M | 84.9 M | 85.9 M | 85.4 M | 85.5 M | 85.1 M | 84.8 M | 86 M | - |
Historical Prices |
55.7 | 48.7 | 58.7 | 65.5 | 62.7 | 44.1 | 75.4 | 77.1 | 120 | 131 | 117 | 94.3 | 84 | ||||
Net Income |
-21.3 M | 56.5 M | -26.8 M | -57.3 M | -347 M | -245 M | 42.4 M | 206 M | 267 M | 326 M | 311 M | 268 M | 235 M | 208 M | 176 M | 149 M | - |
Revenue |
2.66 B | 2.7 B | 2.65 B | 2.68 B | 3.31 B | 853 M | 888 M | 3.56 B | 2.99 B | 2.56 B | 2.14 B | 1.91 B | 1.68 B | 1.44 B | 1.18 B | 1.08 B | - |
Cost of Revenue |
1.64 B | 1.68 B | 1.63 B | 1.62 B | 2.13 B | 2.11 B | 2.12 B | 2.08 B | 1.73 B | - | - | - | - | 733 M | 596 M | 574 M | - |
Gross Profit |
1.01 B | 1.03 B | 1.02 B | 1.05 B | 1.17 B | 1.38 B | 1.46 B | 1.49 B | 1.25 B | 1.09 B | 253 M | 227 M | 202 M | 182 M | 147 M | - | - |
Operating Income |
77.3 M | 154 M | 72.3 M | 31.9 M | -212 M | -161 M | -7.6 M | 434 M | 488 M | 556 M | 536 M | 469 M | 424 M | 371 M | 315 M | 274 M | - |
Interest Expense |
-100 K | 700 K | 300 K | -6 M | -9.5 M | 107 M | 94 M | 97.8 M | 77.5 M | 66.1 M | 55.2 M | 51.7 M | 49.4 M | 37.1 M | 34.3 M | 33.1 M | - |
EBITDA |
182 M | 262 M | 178 M | 140 M | -84.3 M | -35.5 M | 124 M | 557 M | 570 M | 628 M | 597 M | 523 M | 474 M | 388 M | 326 M | 283 M | - |
Operating Expenses |
- | - | - | - | 1.06 B | 1.18 B | 1.47 B | 1.07 B | 779 M | 538 M | 429 M | 388 M | 378 M | - | - | - | - |
General and Administrative Expenses |
874 M | 888 M | 947 M | 898 M | 1.06 B | 1.17 B | 1.4 B | 1.05 B | 767 M | 490 M | 391 M | 357 M | 312 M | 280 M | 217 M | 194 M | - |
All numbers in USD currency
Quarterly Income Statement Stericycle
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | 2010-Q3 | 2010-Q2 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
92.7 M | 92.7 M | 92.6 M | 92.6 M | 92.5 M | 92.5 M | 92.3 M | 92.2 M | 92.2 M | 92.1 M | 92 M | 91.9 M | 91.9 M | 91.8 M | 91.6 M | 91.6 M | 91.5 M | 91.4 M | 91.3 M | 91.2 M | 91.1 M | 91 M | 90.7 M | 90.7 M | 86.7 M | 85.6 M | 85.5 M | 85.5 M | 85.3 M | 85.3 M | 85.2 M | 85.2 M | 85 M | 84.9 M | 84.7 M | 84.9 M | 84.9 M | 85 M | 85 M | 84.9 M | 84.9 M | 84.7 M | 85.3 M | 85.5 M | 85.8 M | 86.1 M | 86.1 M | 86 M | 85.7 M | 85.2 M | 84.8 M | 84.7 M | 85.6 M | 85.9 M | 85.5 M | 85.3 M | 84.9 M |
Net Income |
-13.7 M | 6 M | 13.1 M | - | 2.1 M | -49.5 M | 11.3 M | - | 28 M | 10.5 M | -14.1 M | - | -65.9 M | 29.3 M | 26.2 M | 48.5 M | -80.9 M | -4.5 M | -20.1 M | -219 M | -59.2 M | -30.5 M | -37.8 M | -318 M | 23.5 M | 27.7 M | 22.5 M | 89.2 M | 39 M | -144 M | 58.2 M | 18.7 M | 64.8 M | 46 M | 76.8 M | 80.8 M | 52.3 M | 60.4 M | 75.5 M | 82.5 M | 82.8 M | 81.9 M | 79.1 M | 78.2 M | 80.5 M | 78 M | 74.6 M | 70.1 M | 65.5 M | 67.6 M | 64.9 M | 64.3 M | 59.2 M | 55.5 M | 55.7 M | 56.7 M | 53.1 M |
Revenue |
648 M | 662 M | 665 M | - | 654 M | 670 M | 684 M | - | 690 M | 680 M | 664 M | - | 649 M | 673 M | 668 M | 656 M | 636 M | 598 M | 785 M | 800 M | 833 M | 846 M | 830 M | 853 M | 855 M | 918 M | 895 M | 888 M | 883 M | 918 M | 892 M | 906 M | 890 M | 892 M | 874 M | 888 M | 719 M | 716 M | 663 M | 677 M | 668 M | 641 M | 570 M | 568 M | 535 M | 527 M | 514 M | 504 M | 480 M | 469 M | 460 M | 447 M | 421 M | 410 M | 398 M | 363 M | 348 M |
Cost of Revenue |
404 M | 404 M | 410 M | - | 408 M | 418 M | 423 M | - | 424 M | 419 M | 420 M | - | 409 M | 404 M | 407 M | - | 369 M | 368 M | 498 M | - | 538 M | 543 M | 533 M | - | 519 M | 530 M | 536 M | - | 515 M | 536 M | 524 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 220 M | 214 M | 206 M | 186 M | 177 M |
Gross Profit |
244 M | 258 M | 255 M | - | 246 M | 251 M | 261 M | - | 266 M | 260 M | 244 M | - | 240 M | 269 M | 261 M | 270 M | 267 M | 230 M | 287 M | 280 M | 295 M | 303 M | 297 M | 329 M | 336 M | 353 M | 358 M | 344 M | 368 M | 382 M | 369 M | 367 M | 379 M | 381 M | 367 M | 380 M | 300 M | 305 M | 281 M | 285 M | 279 M | 275 M | 255 M | 253 M | 241 M | 238 M | 232 M | 227 M | 216 M | 209 M | 205 M | 202 M | 190 M | 187 M | 182 M | - | - |
Operating Income |
9 M | 30.5 M | 38.9 M | - | 24.2 M | -24 M | 40 M | - | 50.6 M | 38.1 M | 5.9 M | - | -50.6 M | 55.6 M | 59.1 M | - | -55.8 M | 24.9 M | -30.4 M | - | -34.5 M | 25.3 M | -4.2 M | - | 68.3 M | 62.4 M | 54.1 M | - | 93.6 M | -192 M | 115 M | - | 125 M | 99.7 M | 141 M | - | 100 M | 110 M | 127 M | - | 140 M | 145 M | 133 M | - | 135 M | 134 M | 132 M | - | 115 M | 118 M | 116 M | - | 105 M | 102 M | 102 M | 96 M | 93.6 M |
Interest Expense |
- | -100 K | - | - | 100 K | -600 K | 200 K | - | 2.3 M | -700 K | -800 K | - | 500 K | 700 K | -700 K | - | -900 K | -1 M | -2.9 M | - | -3.2 M | -1.8 M | -2.2 M | - | -6.2 M | -600 K | -1.5 M | - | 24.6 M | 23.8 M | 23.4 M | - | 24.7 M | 24.4 M | 24.1 M | - | 17.4 M | 16.4 M | 18.6 M | - | 16.6 M | 16.4 M | 14.9 M | - | 13.5 M | 13 M | 13.5 M | - | 13 M | 12.8 M | 12.8 M | - | 12 M | 13 M | 11.4 M | 8.51 M | 8.87 M |
EBITDA |
85.6 M | 81.6 M | 64.6 M | - | 103 M | 28.6 M | 66.6 M | - | 132 M | 92.4 M | 33.2 M | - | 27.3 M | 106 M | 84.6 M | - | 27.5 M | 81.9 M | -2.4 M | - | 62.1 M | 90 M | 27.6 M | - | 100 M | 95.1 M | 84.9 M | 29.9 M | 182 M | -134 M | 144 M | 27 M | 219 M | 162 M | 171 M | 18.5 M | 156 M | 147 M | 146 M | - | 195 M | 180 M | 149 M | - | 181 M | 164 M | 146 M | - | 154 M | 143 M | 129 M | - | 121 M | 118 M | 118 M | 110 M | 106 M |
General and Administrative Expenses |
225 M | 228 M | 216 M | - | 217 M | 221 M | 216 M | - | 216 M | 222 M | 239 M | - | 279 M | 214 M | 202 M | - | 219 M | 201 M | 259 M | - | 247 M | 277 M | 280 M | - | 267 M | 291 M | 304 M | - | 238 M | 538 M | 219 M | - | 212 M | 222 M | 202 M | - | 186 M | 182 M | 141 M | - | 126 M | 118 M | 112 M | - | 96.7 M | 94.8 M | 91 M | - | 93 M | 84.4 M | 81.9 M | - | 72.6 M | 72.3 M | 70 M | 65 M | 63.6 M |
All numbers in USD currency
The income statement is one of the three key financial reports of a company Stericycle (alongside the balance sheet and the cash flow statement). It shows how the company makes money and what its expenses are:
- How much revenue the company earned
- How much it spent on production, personnel, marketing, taxes, etc.
- What profit remained in the end
Analyzing the income statement helps an investor understand whether the business generates stable and growing profits, how effectively the company controls its expenses, and whether it is capable of generating income in the future. Additionally, this analysis shows how the company copes with crises and economic cycles, and allows assessing the potential for stock price growth and dividend payments.
Features- The income statement may include both recurring and one-time items (for example, profit from the sale of assets). It is necessary to separate core metrics from one-off events for accurate analysis.
- Companies often publish interim reports (e.g., quarterly), which allows for more timely tracking of trends.
- A combined analysis of the income statement with the balance sheet and cash flow statement provides a comprehensive view of the company’s financial health.